10.3 C
London
Sunday, February 23, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Docetaxel Accord | European Medicines Agency (EMA)

OverviewDocetaxel Accord is a cancer medicine used to treat the following types of cancer:breast cancer. Docetaxel Accord can be used on its own...

Bortezomib Fresenius Kabi | European Medicines Agency (EMA)

OverviewBortezomib Fresenius Kabi is a medicine used to treat multiple myeloma, a blood cancer, in the following groups of patients:previously untreated adults who...

Locametz | European Medicines Agency (EMA)

OverviewLocametz is a diagnostic medicine used in adults with prostate cancer to detect prostate cancer cells with a protein called prostate‑specific membrane antigen...

Dafiro HCT | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

Actelsar HCT | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Actelsar HCT. It explains how the Agency assessed the medicine to...

Wyost | European Medicines Agency (EMA)

OverviewWyost is a medicine used to prevent bone complications in adults with advanced cancer that has spread to the bone. These complications include...

EMA Open Door Day | European Medicines Agency (EMA)

Event summary As part of the celebrations of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img